HR Execs on the Move

Coventry Health Care

www.coventryhealthcare.com

 
Coventry Health Care, Inc. (Coventry) is a diversified national insurer in the United States. Based in Bethesda, Maryland, Coventry operates health plans, insurance companies, network rental and workers’ compensation services companies. Coventry provides a full range of risk and fee-based managed care products and services to a broad cross section of individuals, employer and government-funded groups, government agencies, and other insurance carriers and administrators. It is currently ranked the third most successful prescription drug plan service in the United States.
  • Number of Employees: 5K-10K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

A.R.E.B.A. Casriel

A.R.E.B.A. Casriel is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Radiology Associates of North Texas

Radiology Associates of North Texas is a private practice provider of high quality diagnostic and interventional radiology services. With over 240 Texas based radiologists, our practice provides a level of service and subspecialty expertise to North Te...

ControlRad Systems

ControlRad is a privately-held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures (FGIP) for patients and healthcare professionals.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.